HIV-1 indirectly affects uptake of Leishmania inside monocyte-derived macrophages

	Tweet

HIV-1 indirectly affects the uptake of Leishmania parasites inside monocyte-derived macrophages.

“Concurrent uncontrolled development of human immunodeficiency virus type 1 (HIV-1) and Leishmania spp. is regarded as an emerging pathogenic combination in countries where human beings are exposed to these two micro-organisms.

“The present study was aimed at exploring whether HIV-1 development within a culture of human monocyte-derived macrophages (MDMs) affected the further development of luciferase-encoding Leishmania infantum using the luciferase activity as a readout assay,” scientists in Canada report.

According to C.Q. Zhao and colleagues at Laval University in Quebec City, “It was demonstrated that, in cultures of HIV-1-loaded MDMs; exposed to axenic amastigotes, the luciferase activity was higher than in HIV-1-free MDMs.

“As a preliminary approach to deciphering the possible mechanism through which HIV-1 can affect Leishmania infantum, attention was focused on the very early processes that could underlie this increased luciferase activity.”

“Using GFP-labeled parasites, it was possible to establish that, in HIV-1-infected MDMs, the percentage of GFP-expressing MDMs was higher (10-20%) than in cell cultures not exposed to HIV-1 (5%).

“Two-color immunofluorescence staining suggested that HIV-1 indirectly affects the uptake of parasites inside MDMs. Thus, the observed phenomenon seems to be linked with a higher uptake of parasites within MDMs,” researchers wrote.

“Taken together,” concluded Zhao, “the data reported here may contribute to our understanding of disseminated Leishmania infection in HIV-1-infected individuals.”

Zhao and colleagues published their study in the Journal of General Virology (In primary human monocyte-derived macrophages exposed to Human immunodeficiency virus type 1, does the increased intracellular growth of Leishmania infantum rely on its enhanced uptake? J Gen Virol, 2006;87(Part 5):1295-1302).

For more information, contact M.J. Tremblay, CHUL, Research Center, Research Center Infectious Disease, RC709, 2705 Laurier Blvd., Quebec City, PQ G1V 4G2, Canada.

Publisher contact information for the Journal of General Virology is: Society General Microbiology, Marlborough House, Basingstoke Rd., Spencers Woods, Reading RG7 1AG, Berks, England.

RELATED STORIES:
FDA Advisory Panel Approves Home HIV Test Kit   FDA Approves New In-Home HIV Test   Home HIV test advances   Survey Reveals Support for Over-the Counter HIV Testing   F.D.A. Panel Weighs Preventive Use of H.I.V. Drug   Stem Cell Therapy Shows Promise in Fight Against HIV   Progress against HIV thwarted by patients’ unmet needs   California to test pill for HIV prevention   Mechanism of HIV spread has potential for future drug therapy   Seeking HIV treatment clues in the neem tree   HIV Prevention Pill’s Value Varies by Target   Using AIDS drugs to prevent infection: a bargain?

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]